As of January 22, 2025, JD Health (6618.HK) has a market cap of $12.10 billion USD. According to our data, JD Health is ranked No.1427 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $12.10 B |
4.25%
|
Dec 31, 2024 | $11.61 B |
-27.75%
|
Dec 29, 2023 | $16.06 B |
-45.20%
|
Dec 30, 2022 | $29.31 B |
15.45%
|
Dec 31, 2021 | $25.39 B |
-58.52%
|
Dec 31, 2020 | $61.22 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alibaba Health Information Technology
0241.HK
|
$6.88 B |
-0.310 B
|
Hong Kong
|
111, Inc.
YI
|
$38.55 M |
16.200 M
|
China
|
China Resources Pharmaceutical Group
3320.HK
|
$4.08 B |
-0.048 B
|
Hong Kong
|
Sinopharm
1099.HK
|
$3.50 B |
8.618 M
|
China
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Market Cap | = | 6618.HK Stock Price | * | 6618.HK Shares Outstanding |
= | $3.78 | * | 3.20 B | |
= | $12.10 B |